RS3-48922-87212
3 vaccinations
1 coded response
22 check-ins
0 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 970 / OR
- Registered
- 2021-05-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
JWX-12331-60598
Child or adolescent in my care · Female · 2022-04-30
Timeline
-
2021-05-21
Registered in v-safe
-
2021-05-22
Dose 1 — Pfizer-BioNTech
- 2021-05-22
-
2021-05-23
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness, Itching · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-24
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness, Itching · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-25
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Itching · Fatigue or tirednessAdult check-in
- 2021-05-26
- 2021-05-28
- 2021-05-29
- 2021-06-05
-
2021-06-12
Dose 2 — Pfizer-BioNTech
-
2021-06-13
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-06-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-06-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-06-16
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Itching · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-06-17
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Chills, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-06-18
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Itching · Fatigue or tirednessAdult check-in
- 2021-06-19
- 2021-06-27
- 2021-07-03
- 2021-07-10
- 2021-07-19
- 2021-07-24
- 2021-09-11
-
2022-01-10
Dose 3 — Pfizer-BioNTech
-
2023-01-10
Survey response — 12 months, dose 3MedDRA: Amenorrhoea, Dyspnoea, Palpitations — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitMedDRA releases: 2024-11
-
2023-01-10
Report sent to call center — 12 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2023-01-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-22 | Pfizer-BioNTech | |
| 2 | 2021-06-12 | Pfizer-BioNTech | |
| 3 | 2022-01-10 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Amenorrhoea | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Palpitations | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release